Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile tract cancer trial...
Vous n'êtes pas connecté
The first two blood cancer patients in a US-based trial, who had suffered relapses despite having treatment, have now been in remission for up to 120 days after being dosed with Imugene’s azer-cel therapy.
Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile tract cancer trial...
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3...
Autonomix's RF ablation trial for pancreatic cancer pain shows early success, enabling significant pain relief and opioid elimination in responding...
TUESDAY, Oct. 22, 2024 -- At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial...
Findings from phase two trial suggest patients could receive treatment without having to attend a clinic
Tokyo and Basking Ridge, NJ – (October 30, 2024) – The first patients have been dosed in three global, randomized phase 3 trials...
Evergreen Theragnostics, Inc., a clinical─stage radiopharmaceutical company, focused on providing additional treatment options for cancer patients,...
The Cancer Control Agency is ignoring data showing the effectiveness of several drugs which are free to Australian patients, a leading specialist...
New blood tests are now available to screen for colorectal (colon) cancer, providing a simpler alternative to traditional methods. These tests only...
A new study from the MD Anderson Cancer Center reveals that quitting smoking within six months of a cancer diagnosis can significantly improve...